MAM
GenY Medium wins performance marketing mandate for Onco.com
MUMBAI: GenY Medium (GenY) has bagged the digital mandate for Onco.com, a Bengaluru-based healthcare startup that offers Online Cancer Consultations from leading Oncologists in India and the US.
As a part of this mandate from Onco.com, GenY Medium will run hyper-targeted performance marketing campaigns and enable discovery of this personalised care platform by high-quality prospects. In addition to this, GenY will also work on augmenting visibility and brand awareness for them via search engine optimisation.
GenY Medium co-founder and CEO Yashwant Kumar said, “We’ve been on board with Onco.com for more than two months now and it’s been a great experience to work with a team like theirs. We look forward to our continued association with Onco.com and strengthening our position in the healthcare sector.”
Onco.com CEO Rashie Jain added, “Having GenY Medium on board as our digital partner is a good development at this critical growth juncture in our journey. They have a proven track record in the healthcare space and we look forward to working with them.”
With the sole mission of making high-quality healthcare accessible to every cancer patient in the world, Onco.com aspires to become a trusted partner for patients, a one stop destination where cancer patients get the most accurate treatment plan for their condition before they avail the treatment anywhere. They can also get second opinions to validate their existing treatment.
GenY Medium is a full-service digital agency who enhance the digital presence of leading businesses by combining the art of marketing with the science of digital.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
